genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

EBITDA Summary of genOway Société anonyme

  • genOway Société anonyme's latest annual EBITDA in 2023 was 6.35 Million EUR , up 21362.89% from previous year.
  • genOway Société anonyme's latest quarterly EBITDA in 2024 Q2 was 881 Thousand EUR , down 0.0% from previous quarter.
  • genOway Société anonyme reported an annual EBITDA of 536.79 Thousand EUR in 2022, up 103.51% from previous year.
  • genOway Société anonyme reported an annual EBITDA of 523 Thousand EUR in 2021, down -5.06% from previous year.
  • genOway Société anonyme reported a quarterly EBITDA of N/A for 2023 FY, up 21362.89% from previous quarter.
  • genOway Société anonyme reported a quarterly EBITDA of 338.66 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of genOway Société anonyme (2023 - 2009)

Historical Annual EBITDA of genOway Société anonyme (2023 - 2009)

Year EBITDA EBITDA Growth
2023 6.35 Million EUR 21362.89%
2022 536.79 Thousand EUR 103.51%
2021 523 Thousand EUR -5.06%
2020 881.42 Thousand EUR -520.04%
2019 605.13 Thousand EUR -57.59%
2018 -1.12 Million EUR 30.68%
2017 186.69 Thousand EUR 6.01%
2016 1.01 Million EUR 6.45%
2015 1.12 Million EUR -7.05%
2014 1.19 Million EUR 31.09%
2013 794.04 Thousand EUR 75.65%
2012 452.05 Thousand EUR -55.54%
2011 800.4 Thousand EUR -19.16%
2010 1.25 Million EUR 65.59%
2009 759.54 Thousand EUR 0.0%

Peer EBITDA Comparison of genOway Société anonyme

Name EBITDA EBITDA Difference
ABIONYX Pharma SA -3.29 Million EUR 293.032%
ABIVAX Société Anonyme -133.2 Million EUR 104.768%
Adocia SA -22.73 Million EUR 127.937%
Aelis Farma SA -6.34 Million EUR 200.059%
Biophytis S.A. -13.8 Million EUR 146.007%
Advicenne S.A. -6.24 Million EUR 201.71%
IntegraGen SA -52.5 Thousand EUR 12195.975%
Medesis Pharma S.A. -3.84 Million EUR 265.174%
Neovacs S.A. -8.44 Million EUR 175.161%
NFL Biosciences SA -4.04 Million EUR 256.836%
Plant Advanced Technologies SA 72.53 Thousand EUR -8656.032%
Quantum Genomics Société Anonyme -2.87 Million EUR 321.013%
Sensorion SA -22.31 Million EUR 128.461%
Theranexus Société Anonyme -7.38 Million EUR 185.969%
TME Pharma N.V. -5.07 Million EUR 225.212%
Valbiotis SA -6.95 Million EUR 191.312%
TheraVet SA -517.33 Thousand EUR 1327.587%
Valerio Therapeutics Société anonyme -18.91 Million EUR 133.573%
argenx SE -199.5 Million EUR 103.183%
BioSenic S.A. -6.79 Million EUR 193.448%
Celyad Oncology SA -7.76 Million EUR 181.808%
DBV Technologies S.A. -79.53 Million EUR 107.985%
Galapagos NV 51.03 Million EUR 87.557%
Genfit S.A. -28.05 Million EUR 122.64%
GeNeuro SA -14.31 Million EUR 144.356%
Hyloris Pharmaceuticals SA -14.98 Million EUR 142.395%
Innate Pharma S.A. -7.57 Million EUR 183.805%
Inventiva S.A. -101.84 Million EUR 106.236%
MaaT Pharma SA -19.74 Million EUR 132.172%
MedinCell S.A. -20.04 Million EUR 131.681%
Nanobiotix S.A. -34.01 Million EUR 118.668%
Onward Medical N.V. -35.23 Million EUR 118.024%
Oryzon Genomics S.A. -4.43 Million EUR 243.249%
OSE Immunotherapeutics SA -23.26 Million EUR 127.296%
Oxurion NV -16.72 Million EUR 137.963%
Pharming Group N.V. 4.98 Million EUR -27.5%
Poxel S.A. -12.17 Million EUR 152.145%
GenSight Biologics S.A. -21.73 Million EUR 129.226%
Transgene SA -27.02 Million EUR 123.5%
Financière de Tubize SA 184.57 Thousand EUR -3340.817%
UCB SA 1.26 Billion EUR 99.5%
Valneva SE -64.51 Million EUR 109.844%
Vivoryon Therapeutics N.V. -28.35 Million EUR 122.399%